Your browser doesn't support javascript.
loading
Progress of BCR-ABL fusion gene and JAK2 V617F mutation double-positive myeloproliferative neoplasms / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma ; (12): 637-640, 2022.
Article en Zh | WPRIM | ID: wpr-954011
Biblioteca responsable: WPRO
ABSTRACT
Myeloproliferative neoplasms (MPN) are a group of clonal disorders of hematopoietic stem cells, and JAK2 V617F gene mutation is the main basis for the diagnosis of MPN. Previous studies have shown that BCR-ABL fusion gene and JAK2 V617F gene mutation are mutually exclusive in MPN patients, but in recent years, patients with a double mutation of both genes are often reported. The article synthesizes the relevant domestic and foreign literature in recent years, and reviews the BCR-ABL fusion gene and JAK2 V617F mutation double-positive MPN.
Palabras clave
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Journal of Leukemia & Lymphoma Año: 2022 Tipo del documento: Article
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Journal of Leukemia & Lymphoma Año: 2022 Tipo del documento: Article